Please Upload related files below
Fill in below.
Tell us the stocks you own using SnapTrade, and we will keep you informed about class action litigation related to your stocks. We monitor critical case developments that may affect the price of your shares and your possible monetary recovery. SnapTrade only shares the tickers you own and your transaction history, not your account numbers. Using SnapTrade and participating in our monitoring service is free and does not create any attorney-client relationship or obligation on your part.
Don’t miss out on possible monetary recovery - link your account with SnapTrade.
An Illinois jury returned a $60 million verdict against Reckitt on March 15, 2024. The verdict was the first lawsuit related to necrotizing enterocolitis (“NEC”) that reached a verdict. A second jury awarded $95 million on July 29, 2024, to the plaintiff in a NEC case against the Company’s competitor, Abbott. Following on this news, the Company’s American Depositary Receipts (“ADRs”) fell sharply. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.